134 related articles for article (PubMed ID: 4956319)
1. [Raubasine in combination with ergot alkaloid derivatives in the therapy of closed injuries of the brain].
Stoppani L
Arch Sci Med (Torino); 1965 Nov; 120(5):431-9. PubMed ID: 4956319
[No Abstract] [Full Text] [Related]
2. [Effect of raubasine and dihydroergocristine on arteriosclerotic and hypertensive cerebral diseases].
Klein K
Vasa; 1973; 2(4):409-14. PubMed ID: 4202492
[No Abstract] [Full Text] [Related]
3. [Study of the association of raubasine and dihydroergocristine in the aged patient with vascular disease].
Sauter R
Lille Med; 1971; 17():Suppl 3:551-8. PubMed ID: 5005074
[No Abstract] [Full Text] [Related]
4. [The association of raubasine and ergot derivatives in therapy of peripheral vascular diseases].
Sforza M; Perelli-Ercolini M
Minerva Cardioangiol; 1967 Oct; 15(10):655-8. PubMed ID: 5611109
[No Abstract] [Full Text] [Related]
5. [Quantitative rheographic study of the effects of a new drug combination: raubasine/dihydroergocristine].
Henriet M; Jacquy J; Noel G
Brux Med; 1974 Dec; 54(12):743-5. PubMed ID: 4215548
[No Abstract] [Full Text] [Related]
6. [Therapy of migraine].
Dieckmann H
Dtsch Med Wochenschr; 1968 Dec; 93(50):2444-6. PubMed ID: 4972428
[No Abstract] [Full Text] [Related]
7. [Clinical contribution to the therapy of senile vascular diseases].
Ceino A; Vizioli A
Clin Ter; 1966 May; 37(3):242-50. PubMed ID: 5962630
[No Abstract] [Full Text] [Related]
8. [Use of peripheral vasodilator drug in peripheral and cerebrovascular syndromes of old age].
Andalò L; Missana M
Clin Ter; 1975 Sep; 74(5):471-84. PubMed ID: 819202
[No Abstract] [Full Text] [Related]
9. [Clinical experience with a new peripheral vasodilator agent, in which are combined raubasine, and 2 ergot alkaloids in the treatment of peripheral diabetic angiopathy].
Martínez-López JM; Calvo-Fernández R; Garrido-Toro A; Sánchez-Cañaveral F
Angiologia; 1973; 25(4):195-8. PubMed ID: 4717702
[No Abstract] [Full Text] [Related]
10. [Study of Iskedyl in otoneurologic ischemia].
Duchamps B
JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1974 Sep; 23(7):649-53. PubMed ID: 4280429
[No Abstract] [Full Text] [Related]
11. [Clinical examination of a combined antihypersensitive agent containing hydrogenated ergot alkaloid].
Wanner J
Schweiz Med Wochenschr; 1968 Aug; 98(32):1196-201. PubMed ID: 4974016
[No Abstract] [Full Text] [Related]
12. [Headaches in patients with vascular deficiency and their treatment with a raubasine-dihydroergocristine association].
Henry P
Bord Med; 1972 Nov; 5(18):2531-4. PubMed ID: 4196611
[No Abstract] [Full Text] [Related]
13. [Clinical test of Iskedyl in cochlear and vestibular chronic diseases].
Muler H; Prache H
Ann Otolaryngol Chir Cervicofac; 1976; 93(4-5):325-7. PubMed ID: 821378
[No Abstract] [Full Text] [Related]
14. [Electroencephalographic and clinical study of the action of hydrogen derivatives of Ergotoxin].
Borenstein P; Cujo P; Bahon L
Ann Med Psychol (Paris); 1969 Oct; 2(3):410-24. PubMed ID: 4983442
[No Abstract] [Full Text] [Related]
15. [Effect of the combination of raubasine and hydrogenated ergot alkaloids on the isolated and perfused rat caudal artery and rabbit internal carotid artery].
Miragoli G; Ferrini R
Boll Soc Ital Biol Sper; 1974 Oct; 50(19):1622-8. PubMed ID: 4218491
[No Abstract] [Full Text] [Related]
16. Leriche syndrome in a patient with prolonged and continuous use of ergot derivatives. A review of the vascular effects of ergot.
Pader E
Vasc Dis; 1967 Dec; 4(6):380-8. PubMed ID: 4965290
[No Abstract] [Full Text] [Related]
17. [Defluine (an association of raubasine and ergot derivatives) in the treatment of senile cerebral vascular diseases of a sclerotic nature].
Turri C
Minerva Med; 1970 Aug; 61(65):3466-76. PubMed ID: 5451093
[No Abstract] [Full Text] [Related]
18. [Clinical experimentation with a combination of substances having vasodilator effects on the cerebral circulation].
Barbi G; Tallone G
Minerva Med; 1967 Feb; 58(13):489-91. PubMed ID: 6021620
[No Abstract] [Full Text] [Related]
19. [Autonomic system and postoperative thromboembolism in older gynecologic patients].
Wille P; Randow H; Riess D
Geburtshilfe Frauenheilkd; 1967 May; 27(5):500-8. PubMed ID: 4969244
[No Abstract] [Full Text] [Related]
20. [Modern therapy of the stabilization of essential hypertension by using a new drug combination: Bridina].
Bernik V
Hospital (Rio J); 1969 Aug; 76(2):589-99. PubMed ID: 4981741
[No Abstract] [Full Text] [Related]
[Next] [New Search]
